RAPIDS is a Decision Support System that provides guidance pertaining to the importance of an accurate diagnosis and appropriate, personalized treatment for mental illnesses. By supporting diagnostic rigor and providing personalized treatment guidance, RAPIDS can reduce symptom severity and illness duration and contribute to a patient’s return to full function, more quickly than treatment-as-usual. This is especially true when RAPIDS is utilized closer to the time of illness onset.

Currently, RAPIDS reviews an individual’s diagnosis, and, if it is not supported by validated clinical scales, suggests the clinician consider an alternative diagnosis. RAPIDS provides treatment guidance, for the clinician to consider with their patient, for generalized anxiety disorder, major depressive disorder, bipolar disorder, insomnia and ADHD. RAPIDS also reviews current medication information – including recommendations for initiating, optimizing, augmenting, and switching treatments.

How it Works

Using an industry-standard rules engine, RAPIDS systematically guides the clinical user through an optimized decision pathway. The output is based on medical information provided by the patient and their clinician. Using widely used, validated clinical scales and the DSM-5-TR, RAPIDS evaluates the diagnosis and offers information about potential bio-psycho-social treatment options. The RAPIDS Guidance Report is shared with the patient’s treating clinician, who is urged to consider the diagnostic information and review the treatment guidance with their patient.

RAPIDS is a novel (patent pending) technology designed to substantively elevate mental healthcare quality and access for patients, practitioners, insurers, and employers.


Science is the foundation of the RAPIDS Decision System Strategy. The RAPIDS rules logic and knowledge base is solidly grounded in the most up-to-date, peer-reviewed empirical evidence. 

RAPIDS guidance is further informed by respected international guidelines and a vast body of clinical experience, making it immediately implementable.

The Ontario Brain Institute (OBI), a world leader in brain research, commercialization, and care, has provided assistance with the clinical validation of RAPIDS, by providing objective, independent, clinical feedback through a network of leading key opinion leaders (KOLs) who are experts in the mental health space. KOLs include general practitioners, nurse practitioners, psychiatrists and pharmacology experts.

PsychedUp is a continuing medical education program devoted to improving patient care by providing high-quality, evidence-informed psychiatric education to healthcare professionals.